🇺🇸 FDA
Patent

US 10857219

Compositions comprising soluble HLA/M. tuberculosis-specific ligand complexes and methods of production and use thereof

granted A61KA61K2039/605A61K39/04

Quick answer

US patent 10857219 (Compositions comprising soluble HLA/M. tuberculosis-specific ligand complexes and methods of production and use thereof) held by United States Government as represented by the Department of Veterans Affairs expires Mon Dec 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States Government as represented by the Department of Veterans Affairs
Grant date
Tue Dec 08 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K2039/605, A61K39/04